Collective Family Office’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Collective Family Office’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,952	Closed	-$266K	–	166
2024 Q4	$266K	Sell	2,952 -333	-10%	-$32.3K	0.07%	147
2024 Q3	$325K	Buy	3,285 +727	+28%	+$71.4K	0.09%	139
2024 Q2	$237K	Buy	+2,558	New	+$229K	0.07%	162
2023 Q3	–	Sell	-4,200	Closed	-$349K	–	181
2023 Q2	$349K	Sell	4,200 -150	-3%	-$12.5K	0.14%	128
2023 Q1	$332K	Sell	4,350 -1,980	-31%	-$164K	0.14%	126
2022 Q4	$525K	Buy	6,330 +1,770	+39%	+$143K	0.24%	89
2022 Q3	$362K	Buy	4,560 +1,650	+57%	+$139K	0.18%	118
2022 Q2	$216K	Buy	+2,910	New	+$218K	0.09%	174

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Collective Family Office's XBI Position: Q1 2025 in Review

Collective Family Office sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 2,952 shares — an estimated $266K sold.

Collective Family Office first reported a position in XBI in Q2 2022 and held it in 8 quarters. The position peaked at $525K in Q4 2022. 682 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Collective Family Office reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
Collective Family Office sold 2,952 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $266K.
Collective Family Office first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 8 quarters.
Collective Family Office's State Street SPDR S&P Biotech ETF position peaked at $525K in Q4 2022.
682 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Collective Family Office's 13F filing for Q1 2025, filed 3 Apr 2025.